HHV8-Related Malignant Neoplasm — Trials

HHV8-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

146 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01412515	A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma	terminated	Phase 2	11	Institut National de la Santé Et de la Recherche Médicale, FranceOTHER_GOV	1	Jun 4, 2026	clinicaltrials
NCT01752569	A Study of Selumetinib in Patients With Kaposi's Sarcoma(SCART)	terminated	Phase 1 / Phase 2	19	Sheffield Teaching Hospitals NHS Foundation Trust